One of the facts that has become crystal clear in the wake of the coronavirus crisis is that we need to be moving the production of pharmaceuticals the heck out of China and get it back stateside. Especially after China threatened the production of needed medications when they were criticized for their handling of the outbreak they caused.
Yes, ladies and gentlemen. The evidence is pretty clear. China is where this bad boy started. If they had taken proper steps to contain the disease and shared information like they were supposed to thousands of lives could’ve been saved.
Well, the Trump administration is now taking bold steps to bring the production of medication back to America and away from China and India. About darn time.
Here’s more from The Daily Wire:
“Seeking to secure the nation’s supply of critical medications, the Trump administration has signed a $354 million contract that would create the nation’s first strategic stockpile of key ingredients needed to make medicines,” NBC News reported. “The agreement was signed Monday with Phlow Corp., a generic drug maker based in Virginia.”
White House Trade Adviser Peter Navarro, a staunch China hawk who is the mastermind behind President Donald Trump’s trade war with the communist nation, said that the move “will not only help bring our essential medicines home but actually do so in a way that is cost competitive with the sweatshops and pollution havens of the world.”
Navarro went on to say, “This is an historic turning point in America’s efforts to onshore its pharmaceutical production and supply chains.”
This is a perfect example of what an “America first” agenda looks like, and honestly, it’s a sight for sore eyes. We should never be completely dependent on another country for something as important as lifesaving medications. Right off the bat that’s a horrible idea. It’s sad it took this sort of crisis to get something done about it, but hey, it’s a silver lining on a very bad situation.
Here’s to hoping this gets done sooner rather than later.